Published in Orphanet J Rare Dis on May 24, 2012
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2015) 1.47
Fibrous Dysplasia: Management of the Optic Canal. Plast Reconstr Surg (2016) 1.39
Fibroblast growth factor 23: state of the field and future directions. Trends Endocrinol Metab (2012) 1.21
Somatic mosaicism in the human genome. Genes (Basel) (2014) 0.99
Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics. Mol Cell Endocrinol (2013) 0.95
Neonatal McCune-Albright syndrome with systemic involvement: a case report. J Med Case Rep (2015) 0.90
Acromegaly and McCune-Albright syndrome. J Clin Endocrinol Metab (2014) 0.90
Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives. Curr Osteoporos Rep (2016) 0.90
Locally aggressive fibrous dysplasia mimicking malignancy: a report of four cases and review of the literature. Clin Orthop Relat Res (2014) 0.87
GNAS Spectrum of Disorders. Curr Osteoporos Rep (2015) 0.87
Fibrous dysplasia and fibroblast growth factor-23 regulation. Curr Osteoporos Rep (2013) 0.83
Oral pigmentation in McCune-Albright syndrome. JAMA Dermatol (2014) 0.77
A high throughput screening assay system for the identification of small molecule inhibitors of gsp. PLoS One (2014) 0.77
Wnts' fashion statement: from body stature to dysplasia. Bonekey Rep (2014) 0.77
Etiology and therapeutic outcomes of children with gonadotropin-independent precocious puberty. Ann Pediatr Endocrinol Metab (2016) 0.75
Fibrous dysplasia and cherubism. Indian J Plast Surg (2016) 0.75
Treatment of Peripheral Precocious Puberty. Endocr Dev (2015) 0.75
Fibrous dysplasia of bone: craniofacial and dental implications. Oral Dis (2016) 0.75
A Suspected Case and Literature Review of McCune-Albright Syndrome. Ann Dermatol (2014) 0.75
Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome. Eur J Endocrinol (2016) 0.75
Low serum free thyroxine level in a girl with McCune-Albright syndrome. BMJ Case Rep (2015) 0.75
Toxic Thyroid Adenoma in McCune-Albright Syndrome. J Clin Diagn Res (2014) 0.75
Incretin therapy and pancreatic pathologies: background pathology versus drug-induced pathology in rats. Diabetes (2014) 0.75
Clinical and endocrine characteristics and genetic analysis of Korean children with McCune-Albright syndrome: a retrospective cohort study. Orphanet J Rare Dis (2016) 0.75
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med (1991) 7.17
GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature (1989) 5.03
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest (2003) 3.60
McCune-Albright syndrome. Orphanet J Rare Dis (2008) 2.45
Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A (1992) 2.26
A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res (2011) 2.00
Malignancies in fibrous dysplasia. Cancer (1994) 1.91
Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med (2002) 1.47
The McCune-Albright syndrome. Acta Endocrinol Suppl (Copenh) (1986) 1.46
Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome. J Bone Miner Res (2003) 1.39
Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res (2001) 1.38
Acromegaly and cardiovascular disorders. A prospective study. Ann Intern Med (1974) 1.37
Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab (2003) 1.36
Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J Pediatr (1999) 1.33
Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab (2002) 1.28
Long-term outcome of optic nerve encasement and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation. Neurosurgery (2006) 1.23
Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control (2002) 1.23
Endocrine features in Albright's syndrome (fibrous dysplasia of bone). Metabolism (1962) 1.23
Malignant change secondary to fibrous dysplasia. Int J Clin Oncol (2006) 1.21
Fibrous dysplasia with cartilaginous differentiation ("fibrocartilaginous dysplasia"): a review, with an illustrative case followed for 18 years. Skeletal Radiol (2003) 1.19
Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP. Neuropsychopharmacology (2006) 1.15
Age-dependent demise of GNAS-mutated skeletal stem cells and "normalization" of fibrous dysplasia of bone. J Bone Miner Res (2008) 1.12
McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases. Eur J Endocrinol (1994) 1.09
Fibrous dysplasia of bone and primary hyperparathyroidism. Ann Intern Med (1972) 1.08
The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3'-triiodothyronine toxicosis of McCune-Albright syndrome. J Clin Endocrinol Metab (2008) 1.04
Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome. Am J Surg Pathol (2011) 1.03
Cushing syndrome in the McCune-Albright syndrome. J Clin Endocrinol Metab (2010) 1.00
Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia. Mol Psychiatry (2008) 0.99
Thyroid abnormalities in the McCune-Albright syndrome: ultrasonography and hormonal studies. J Clin Endocrinol Metab (1990) 0.99
Fibrous dysplasia of the spine with sarcomatous transformation: a case report and review of the literature. Eur Spine J (1995) 0.96
Demonstration of McCune-Albright mutations in the liver of children with high gammaGT progressive cholestasis. J Hepatol (2000) 0.95
Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome. J Clin Endocrinol Metab (2006) 0.94
McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients. J Clin Endocrinol Metab (2006) 0.94
Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gs alpha. Neuropsychopharmacology (2004) 0.93
Activating mutation of GS alpha in McCune-Albright syndrome causes skin pigmentation by tyrosinase gene activation on affected melanocytes. Horm Res (1999) 0.93
Cancers associated with acromegaly. Neuroendocrinology (2006) 0.92
Chronically increased Gsalpha signaling disrupts associative and spatial learning. Learn Mem (2006) 0.90
Constitutive activation of the G-protein subunit Galphas within forebrain neurons causes PKA-dependent alterations in fear conditioning and cortical Arc mRNA expression. Learn Mem (2008) 0.90
Growth hormone suppression after an oral glucose load in children. J Clin Endocrinol Metab (2007) 0.87
Fibrous dysplasia of bone with vitamin D resistant rickets: a case study. Metabolism (1968) 0.87
McCune-Albright syndrome: growth hormone and prolactin hypersecretion. J Pediatr Endocrinol Metab (2006) 0.86
Chronic Galphas signaling in the striatum increases anxiety-related behaviors independent of developmental effects. J Neurosci (2008) 0.86
Polyostotic fibrous dysplasia associated with Cushing syndrome. Arch Pathol (1973) 0.85
Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: natural history, long-term follow-up, and SMS 201-995--bromocriptine combined treatment results. J Clin Endocrinol Metab (1992) 0.85
Osteosarcoma of the mandible arising in fibrous dysplasia. A case report. Clin Orthop Relat Res (1986) 0.85
Breast Cancer in a Patient with McCune-Albright Syndrome. Breast Cancer (1998) 0.84
Growth hormone hypersecretion in a girl with McCune-Albright syndrome: comparison with controls and response to a dose of long-acting somatostatin analog. J Clin Endocrinol Metab (1995) 0.84
Osteosarcoma and acromegaly: a case report and review of the literature. J Endocrinol Invest (2006) 0.83
Alteration in cyclic AMP-dependent protein kinases and polyamine biosynthetic enzymes during hypertrophy and hyperplasia of the thyroid in the rat. Mol Pharmacol (1983) 0.83
Treatment of acromegaly with a somatostatin analog in a patient with McCune-Albright syndrome. J Pediatr (1987) 0.82
Mice expressing constitutively active Gsalpha exhibit stimulus encoding deficits similar to those observed in schizophrenia patients. Neuroscience (2006) 0.82
Establishment and characterization of a cell line from a malignant fibrous histiocytoma of bone developing in a patient with multiple fibrous dysplasia. J Cancer Res Clin Oncol (2001) 0.81
Possible relationship of primary hyperparathyroidism and fibrous dysplasia: report of case. J Oral Surg (1977) 0.81
Ductal carcinoma in situ in a 27-year-old woman with McCune-Albright syndrome. Breast J (2004) 0.81
Chondrosarcoma in a patient with McCune-Albright syndrome. Report of a case. Rev Rhum Engl Ed (1999) 0.81
Dedifferentiated chondrosarcoma in Albright syndrome. A case report and review of the literature. J Bone Joint Surg Am (1997) 0.81
A case of McCune-Albright syndrome associated with pituitary GH adenoma: therapeutic process and autopsy. J Pediatr Endocrinol Metab (2011) 0.81
Craniofacial fibrous dysplasia associated with primary hyperparathyroidism. Acta Biomed Ateneo Parmense (1999) 0.80
Platelet dysfunction and increased bleeding tendency in McCune-Albright syndrome. J Pediatr (2008) 0.80
Primary hyperparathyroidism-associated polyostotic fibrous dysplasia: absence of McCune-Albright syndrome mutations. J Endocrinol Invest (1997) 0.80
Osteosarcoma in a pregnant patient with McCune-Albright syndrome. Bone (2009) 0.79
Severe hyperparathyroidism associated with fibrous dysplasia: a case report. Nephron (1996) 0.78
Long-term follow-up of a case of cheek hyperpigmentation associated with McCune-Albright syndrome treated with Q-switched ruby laser. Dermatol Surg (2011) 0.78
McCune-Albright syndrome: how many endocrinopathies can one patient have? South Med J (1993) 0.77
Maxillary malignant mesenchymoma and massive fibrous dysplasia. Arch Otolaryngol Head Neck Surg (1997) 0.77
Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies. Cancer (2004) 1.69
Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease. J Bone Miner Res (2002) 1.66
Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J Clin Invest (2006) 1.52
Weight of normal parathyroid glands in patients with parathyroid adenomas. J Clin Endocrinol Metab (2004) 1.47
Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr (2009) 1.22
Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Clin Cancer Res (2007) 1.19
Multimarker circulating DNA assay for assessing blood of prostate cancer patients. Clin Chem (2009) 1.14
Three novel mutations in SQSTM1 identified in familial Paget's disease of bone. J Bone Miner Res (2003) 1.08
Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease. J Bone Miner Res (2004) 1.05
The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer. Am J Med (2003) 1.00
Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer. Clin Cancer Res (2003) 0.94
Sequestosome 1 (SQSTM1) mutations in Paget's disease of bone from the United States. Calcif Tissue Int (2008) 0.92
Medical management of Paget's disease of bone: indications for treatment and review of current therapies. J Bone Miner Res (2006) 0.90
Acute mental status change as the presenting feature of adrenal insufficiency in a patient with autoimmune polyglandular syndrome type II and stroke. J Pediatr Endocrinol Metab (2014) 0.89
Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients. Cancer Res (2003) 0.87
Clinical and cellular phenotypes associated with sequestosome 1 (SQSTM1) mutations. J Bone Miner Res (2006) 0.87
Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage breast cancer patients. Ann N Y Acad Sci (2006) 0.87
Cinacalcet for the treatment of primary hyperparathyroidism. Metabolism (2008) 0.85
Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. J Bone Miner Res (2003) 0.84
Sentinel lymph node biopsy for papillary thyroid cancer: 12 years of experience at a single institution. Ann Surg Oncol (2010) 0.82
Ascertainment bias in Turner syndrome: new insights from girls who were diagnosed incidentally in prenatal life. Pediatrics (2004) 0.81
A newborn infant with a disorder of sexual differentiation. J Dev Behav Pediatr (2003) 0.81
A newborn infant with a disorder of sexual differentiation. J Dev Behav Pediatr (2004) 0.80
Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab (2012) 0.80
A novel microvascular approach to treatment of the high undescended testicle. J Pediatr Surg (2002) 0.79
An update on the treatment of precocious puberty in McCune-Albright syndrome and testotoxicosis. J Pediatr Endocrinol Metab (2007) 0.78
Response to the letter by Asik M., et al. J Clin Endocrinol Metab (2015) 0.75
Response to letter by Ralston et al. J Clin Endocrinol Metab (2015) 0.75
Response to letter. J Clin Endocrinol Metab (2015) 0.75
Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome. Horm Res Paediatr (2010) 0.75
Congenital Hypothyroidism Long-Term Follow-up Project: Navigating the Rough Waters of a Multi-Center, Multi-State Public Health Project. J Genet Couns (2014) 0.75
Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary hyperparathyroidism and its effect on sestamibi imaging. J Clin Endocrinol Metab (2007) 0.75